Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,561,694,303
+$1,257,176 QoQ
Shares Held
10,086,602
-3.7% QoQ
Ownership
0.419%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#34
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $21,591,255,986 across 16 Drug Manufacturers - General names. JNJ ranks #4 (11.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,590,218 | $5,505,645,627 | |
| 2 | ABBV |
AbbVie Inc.
|
19,925,232 | $5,013,985,374 | |
| 3 | AZN |
Astrazeneca PLC
|
16,511,727 | $3,130,953,667 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
10,086,602 | $2,561,694,303 | |
| 5 | MRK |
Merck & Co., Inc.
|
19,548,585 | $2,511,993,169 | |
| 6 | NVO |
Novo Nordisk A S
|
13,041,109 | $625,190,761 | |
| 7 | NVS |
Novartis AG
|
3,251,281 | $509,540,755 | |
| 8 | AMGN |
Amgen Inc
|
1,365,550 | $494,492,960 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,561,694,303 | 10,086,602 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2,560,437,127 | 10,474,706 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,234,037,244 | 10,795,058 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,992,215,427 | 16,137,501 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,666,927,161 | 17,459,425 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $2,944,762,662 | 17,756,649 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,521,501,612 | 17,435,359 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,729,101,578 | 16,840,069 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $2,208,592,771 | 15,110,788 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,970,965,293 | 12,459,481 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,718,742,653 | 10,965,565 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,807,648,201 | 11,606,088 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,087,973,387 | 12,614,629 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,898,848,890 | 12,250,638 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,179,971,575 | 12,340,626 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $2,030,970,909 | 12,432,486 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,519,717,877 | 14,194,794 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $2,731,764,196 | 15,413,667 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,799,066,152 | 16,362,110 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,647,344,496 | 16,392,226 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,655,323,631 | 16,118,269 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,287,836,140 | 13,920,512 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,336,428,064 | 14,845,775 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $2,072,442,795 | 13,920,223 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,735,734,348 | 12,342,561 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $1,639,304,382 | 12,501,368 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||